Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd.verified

CYTO

Price:

$0.423

Market Cap:

$1.43M

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treat...[Read more]

Industry

Biotechnology

IPO Date

2014-08-06

Stock Exchange

NASDAQ

Ticker

CYTO

The Enterprise Value as of November 2024 (TTM) for Altamira Therapeutics Ltd. (CYTO) is 909.70K

According to Altamira Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 909.70K. This represents a change of -71.76% compared to the average of 3.22M of the last 4 quarters.

Altamira Therapeutics Ltd. (CYTO) Historical Enterprise Value (quarterly & annually)

How has CYTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Altamira Therapeutics Ltd. over the last ten years is 57.99M. The current 909.70K Enterprise Value has changed 56.87% with respect to the historical average. Over the past ten years (40 quarters), CYTO's Enterprise Value was at its highest in in the December 2015 quarter at 279.17M. The Enterprise Value was at its lowest in in the March 2019 quarter at -5791929.00.

Quarterly (TTM)
Annual

Average

57.99M

Median

15.95M

Minimum

918.84K

Maximum

265.45M

Altamira Therapeutics Ltd. (CYTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Altamira Therapeutics Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 568.25%

Maximum Annual Enterprise Value = 265.45M

Minimum Annual Increase = -91.16%

Minimum Annual Enterprise Value = 918.84K

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023918.84K-91.16%
202210.40M-51.66%
202121.51M568.25%
20203.22M-58.36%
20197.73M-25.01%
201810.31M-78.51%
201747.97M-12.27%
201654.68M-79.40%
2015265.45M68.30%
2014157.72M-13.69%

Altamira Therapeutics Ltd. (CYTO) Average Enterprise Value

How has CYTO Enterprise Value performed in the past?

The current Enterprise Value of Altamira Therapeutics Ltd. (CYTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

10.94M

5-year avg

8.76M

10-year avg

57.99M

Altamira Therapeutics Ltd. (CYTO) Enterprise Value vs. Peers

How is CYTO’s Enterprise Value compared to its peers?

Altamira Therapeutics Ltd.’s Enterprise Value is less than Pyxis Oncology, Inc. (121.39M), greater than Zura Bio Limited (-9969663.00), less than eFFECTOR Therapeutics, Inc. (4.74M), less than Elevation Oncology, Inc. (18.49M), less than Immix Biopharma, Inc. (30.53M), greater than Enveric Biosciences, Inc. (202.96K), greater than Palisade Bio, Inc. (-4438971.00), less than CNS Pharmaceuticals, Inc. (0), greater than ZyVersa Therapeutics, Inc. (209.41K), less than VectivBio Holding AG (2.53M), less than AVROBIO, Inc. (848.58M), greater than null (-85302404.00),

Build a custom stock screener for Altamira Therapeutics Ltd. (CYTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altamira Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altamira Therapeutics Ltd. (CYTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altamira Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Altamira Therapeutics Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Altamira Therapeutics Ltd. (CYTO)?

What is the 3-year average Enterprise Value for Altamira Therapeutics Ltd. (CYTO)?

What is the 5-year average Enterprise Value for Altamira Therapeutics Ltd. (CYTO)?

How does the current Enterprise Value for Altamira Therapeutics Ltd. (CYTO) compare to its historical average?